Skip to main content
SpringerLink
Log in

Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

The content of interleukin-8 (IL-8) in the synovial fluid and its production by blood and synovial fluid mononuclear cells (PBMC and SFMC) was compared in rheumatoid arthritis (RA) and various other inflammatory rheumatic disorders. The study included 125 patients and 20 healthy individuals. The highest concentrations of IL-8 were found in the synovial fluids and culture supernatants of PBMC and SFMC from patients with seropositive RA. Only PBMC from seropositive patients, and not from other rheumatic diseases, exhibited significant spontaneous release of IL-8 that correlated with serum IgM rheumatoid factor titers. Gold sodium thiomalate (GST) and methotrexate (MTX) inhibited the spontaneous and stimulated IL-8 production by PBMC by 55–86% at 50 and 10 μg/ml, respectively. Two main conclusions were drawn: (1) rheumatoid factors appeared to be a major cause of enhanced IL-8 production in seropositive RA, and (2) inhibition of IL-8-mediated neutrophil migration and activation could be part of the mechanism of action of GST and MTX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ryan GB (1967) The origin and sequence of the cells found in the acute inflammatory response. Aust J Exp Biol Med Sci 45:149–162

    Google Scholar 

  2. Matsushima K, Oppenheim JJ (1989) Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1:2–13

    Google Scholar 

  3. Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–1049

    Google Scholar 

  4. Watson ML, Westwick J, Fincham NJ, Camp RD (1988) Elevation of PMN cytosolic free calcium and locomotion stimulated by novel peptides from IL-1-treated human synovial cell cultures. Biochem Biophys Res Commun 155:1154–1160

    Google Scholar 

  5. Golds EE, Mason P, Nyirkos P (1989) Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not β2-microglobulin in human synovial cells and fibroblasts. Biochem J 259:585–588

    Google Scholar 

  6. Brennan FM, Zachariae COC, Chantry D, Larsen CG, Turner M, Maini RN, Matsushima K, Feldmann M (1990) Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 20:2141–2144

    Google Scholar 

  7. Seitz M, Dewald B, Gerber N, Baggiolini M (1991) Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 87:463–469

    Google Scholar 

  8. Fernandez HN, Henson PM, Otani A, Hugli TE (1978) Chemotactic response to human C3a and C5a anaphylatoxins, I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J Immunol 120:109–115

    Google Scholar 

  9. Lee TC, Snyder F (1985) Function, metabolism and regulation of platelet activating factor and related ether lipids. In: Kuo JF (ed) Phospholipids and cellular regulation. CRC, Boca Raton, pp 1–39

    Google Scholar 

  10. Ford Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ (1980) Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265

    Google Scholar 

  11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Google Scholar 

  12. Boyum A (1976) Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 5:9–15

    Google Scholar 

  13. Koski JR, Poplak DG, Blaese RMA (1976) Nonspecific esterase stain for the identification of monocytes and macrophages. Academic Press, New York, p 359

    Google Scholar 

  14. Seitz M, Hunstein W (1985) Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus. Ann Rheum Dis 44:438–445

    Google Scholar 

  15. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M (1991) Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 173:771–774

    Google Scholar 

  16. Lindley I, Aschauer H, Seifert JM, Lam C, Brunowsky W, Kownatzki E, Thelen M, Peveri P, Dewald B, Tscharner V von, Walz A, Baggiolini M (1988) Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: Biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 85:9199–9203

    Google Scholar 

  17. Ugai K, Ziff M, Lipsky PE (1979) Gold-induced changes in the morphology and functional capabilities of human monocytes. Arthritis Rheum 22:1352–1360

    Google Scholar 

  18. Salmeron G, Lipsky PE (1982) Modulation of human immune responsiveness in vitro by auranofin. J Rheumatol [Suppl] 8:25–31

    Google Scholar 

  19. Littman BH, Schwartz P (1982) Gold inhibition of the production of the second complement component by lymphokine-stimulated human monocytes. Arthritis Rheum 25:288–296

    Google Scholar 

  20. Ghadially FN, Oryschak AF, Mitchell DM (1976) Ultrastructural changes produced in rheumatoid synovial membrane by chrysotherapy. Ann Rheum Dis 35:67–72

    Google Scholar 

  21. Vernon Roberts B, Dore JL, Jessop JD, Henderson WJ (1976) Selective concentration and localization of gold in macrophages of synovial and other tissues during and after chrysotherapy in rheumatoid patients. Ann Rheum Dis 35:477–486

    Google Scholar 

  22. Nakamura H, Igarashi M (1977) Localization of gold in synovial membrane of rheumatoid arthritis treated with sodium aurothiomalate: Studies by electron microscope and electron probe x-ray microanalysis. Ann Rheum Dis 36:209–215

    Google Scholar 

  23. Jessop JD, Vernon Roberts B, Harris J (1973) Effects of gold salts and prednisolone on inflammatory cells I. Phagocytic activity of macrophages and polymorphs in inflammatory exudates studied by a “skin-window” technique in rheumatoid and control patients. Ann Rheum Dis 32:294–300

    Google Scholar 

  24. Gottlieb NL, Smith PM, Smith EM (1972) Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy. Arthritis Rheum 15:16–22

    Google Scholar 

  25. Kremer JM, Galivan J, Streckfuss A, Kamen B (1986) Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 29:832–835

    Google Scholar 

  26. Strieter RM, Kunkel SL, Showell HJ, Remick GD, Phan SH, Ward PA, Marks RM (1989) Endothelial cell gene expression of a neutrophil chemotactic factor by TNF, IL-1 and LPS. Science 243:1467–1469

    Google Scholar 

  27. Schroder JM, Christophers E (1989) Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol 142:244–251

    Google Scholar 

  28. Sica A, Matsushima K, Van Damme J, Wang JM, Polentarutti N, Dejana E, Colotta F, Mantovani A (1990) IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 69:548–553

    Google Scholar 

  29. Van Damme J, Bunning RAD, Conings R, Graham R, Russell G, Opdenakker G (1990) Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8. Cytokine 2:106–111

    Google Scholar 

  30. Klickstein LB, Shapleigh C, Goetzl EJ (1980) Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest 66:1166–1170

    Google Scholar 

  31. Ward PA, Zvaifler NJ (1971) Complement-derived leukotactic factors in inflammatory synovial fluids of humans. J Clin Invest 50:606–616

    Google Scholar 

  32. Forestier J (1935) Rheumatoid arthritis and its treatment by gold salts. J Lab Clin Med 20:827–840

    Google Scholar 

  33. Penneys NS, McCreary S, Gottlieb NL (1976) Intracellular distribution of radiogold: Localization to large granule membranes. Arthritis Rheum 19:927–932

    Google Scholar 

  34. Gottlieb NL (1985) Gold compounds. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (eds). Saunders, Philadelphia pp 789–809

    Google Scholar 

  35. Petersen J, Bendtzen K (1983) Immunosuppressive actions of gold salts. Scand J Rheumatol [Suppl] 51:28–35

    Google Scholar 

  36. Ho PP, Young AL, Southard GL (1978) Methyl ester of N-formylmethionyl-leucyl-phenylalanine: Chemotactic responses of human blood monocytes and inhibition of gold compounds. Arthritis Rheum 21:133–136

    Google Scholar 

  37. Vernon Roberts B, Jessop JD, Dore J (1973) Effects of gold salts and prednisolone on inflammatory cells II. Suppression of inflammation and phagocytosis in the rat. Ann Rheum Dis 32:301–307

    Google Scholar 

  38. Littman BH, Hall RE (1985) Effects of gold sodium thiomalate on functional correlates of human monocyte maturation. Arthritis Rheum 28:1384–1392

    Google Scholar 

  39. Spalding DM, Darby WL, Heck LW (1986) Alterations in macrophage collagenase secretion induced by gold sodium thiomalate. Arthritis Rheum 29:75–81

    Google Scholar 

  40. Ennis RS, Granda JL, Posner AS (1968) Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases. Arthritis Rheum 11:756–764

    Google Scholar 

  41. Schultz DR, Volanakis JE, Arnold PI, Gottlieb NL, Sakai K, Stroud RM (1974) Inactivation of C1 in rheumatoid synovial fluid, purfied C1 and C1 esterase, by gold compounds. Clin Exp Immunol 17:395–406

    Google Scholar 

  42. Burkhardt D, Stephens RW, Ghosh P, Taylor TK (1978) Inhibition of synovial fluid lysosomal glycosidases by anti-arthritic gold preparations. Agents Actions 8:251–257

    Google Scholar 

  43. Sanders KM, Carlson PL, Littman BH (1987) Effects of gold sodium thiomalate on interferon stimulation of C2 synthesis and HLA-DR expression by human monocytes. Arthritis Rheum 30:1032–1039

    Google Scholar 

  44. Drakes ML, Harth M, Galsworthy SB, McCain GA (1987) Effects of gold on the production of and response to human interleukin-1. J Rheumatol 14:1123–1127

    Google Scholar 

  45. Remvig L, Enk C, Bligaard N (1988) Effect of auranofin and sodium aurothiomalate on interleukin-1 production from human monocytes in vitro. Scand J Rheumatol 17:255–262

    Google Scholar 

  46. Danis VA, Kulesz AJ, Nelson DS, Brooks PM (1990) The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis. Clin Exp Immunol 79:335–340

    Google Scholar 

  47. Furst DE, Kremer JM (1988) Methotrexate in rheumatoid arthritis. Arthritis Rheum 31:305–314

    Google Scholar 

  48. Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth D, Glass DN, Trentham DE (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312:818–822

    Google Scholar 

  49. Kremer JM, Rynes RI, Bartholomew LE (1987) Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study. Am J Med 82:781–786

    Google Scholar 

  50. Cream JJ, Pole DS (1980) The effect of methotrexate and hydroxyurea on neutrophil chemotaxis. Br J Dermatol 102:557–563

    Google Scholar 

  51. Harris ED Jr (1985) Pathogenesis of rheumatoid arthritis. Text-book of Rheumatology. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB (eds) Saunders, Philadelphia, pp 890–893

    Google Scholar 

  52. Sticherling M, Bornscheuer E, Schröder J-M, Christophers E (1991) Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol 96:26–30

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, University Hospital, Inselspital, CH-3010, Bern, Switzerland

    M. Seitz & N. Gerber

  2. Theodor-Kocher Institute, University of Bern, CH-3000, Bern, Switzerland

    B. Dewald & M. Baggiolini

  3. Sandoz Forschungsinstitut, A-1000, Vienna, Austria

    M. Ceska

Authors
  1. M. Seitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Dewald
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Ceska
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Baggiolini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seitz, M., Dewald, B., Ceska, M. et al. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 12, 159–164 (1992). https://doi.org/10.1007/BF00274936

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00274936

Key words

Search

Navigation